ArticleRheumatology and therapy2020

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials.

Jacqueline M Tarrant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.